These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11276286)

  • 1. Antiphospholipid syndrome presenting as portopulmonary hypertension.
    Bayraktar Y; Tanaci N; Egesel T; Gököz A; Balkanci F
    J Clin Gastroenterol; 2001 Apr; 32(4):359-61. PubMed ID: 11276286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe portopulmonary hypertension in congenital hepatic fibrosis.
    Hsu CM; Chiu CT; Lien JM; Ng KF
    Chang Gung Med J; 2003 Mar; 26(3):193-8. PubMed ID: 12790224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy.
    Sandoval J; Amigo MC; Barragan R; Izaguirre R; Reyes PA; Martinez-Guerra ML; Palomar A; Gomez A; Garcia-Torres R
    J Rheumatol; 1996 Apr; 23(4):772-5. PubMed ID: 8730145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic thromboembolic pulmonary hypertension as an uncommon presentation of primary antiphospholipid syndrome.
    Porres-Aguilar M; Pena-Ruiz MA; Burgos JD; Porres-Munoz M; Hughes HW
    J Natl Med Assoc; 2008 Jun; 100(6):734-6. PubMed ID: 18595578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portopulmonary hypertension.
    Mukhtar NA; Fix OK
    J Clin Gastroenterol; 2011 Sep; 45(8):703-10. PubMed ID: 21325952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic portal hypertension during a catastrophic attack in a patient with primary antiphospholipid syndrome.
    Cikrikcioglu MA; Erkal H; Hursitoglu M; Karadag A; Gundogan E; Kayacan SM; Tukek T
    Acta Gastroenterol Belg; 2010; 73(4):521-6. PubMed ID: 21299166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis.
    Sayarlioglu M; Topcu N; Harman M; Guntekin U; Erkoc R
    Rheumatol Int; 2005 Jan; 25(1):65-8. PubMed ID: 15378261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder.
    Ito H; Adachi Y; Arimura Y; Endo T; Hinoda Y; Imai K
    J Gastroenterol; 2003; 38(5):488-92. PubMed ID: 12768393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary manifestations in antiphospholipid syndrome.
    Stojanovich L
    Autoimmun Rev; 2006 May; 5(5):344-8. PubMed ID: 16782560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portopulmonary hypertension: a tale of two circulations.
    Budhiraja R; Hassoun PM
    Chest; 2003 Feb; 123(2):562-76. PubMed ID: 12576381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent.
    Hussein A; Trowitzsch E; Brockmann M
    Klin Padiatr; 1999; 211(2):92-5. PubMed ID: 10407819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome.
    Brucato A; Baudo F; Barberis M; Redaelli R; Casadei G; Allegri F; De Juli E; De Cataldo F
    J Rheumatol; 1994 May; 21(5):942-4. PubMed ID: 8064740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies.
    Luchi ME; Asherson RA; Lahita RG
    Arthritis Rheum; 1992 Jun; 35(6):700-5. PubMed ID: 1599524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic pulmonary hypertension complicated with antiphospholipid syndrome case.
    Miyashita Y; Koike H; Misawa A; Shimizu H; Yoshida K; Yasutomi T
    Intern Med; 1996 Nov; 35(11):912-5. PubMed ID: 8968810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas.
    Krowka MJ
    Hepatology; 1997 May; 25(5):1282-4. PubMed ID: 9141454
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid progression from hepatopulmonary syndrome to portopulmonary hypertension in an adolescent female with hypopituitarism.
    Justino H; Sanders K; McLin VA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):334-6. PubMed ID: 19668006
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of portopulmonary hypertension.
    Medarov BI; Chopra A; Judson MA
    Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Portopulmonary hypertension due to schistosomiasis in two Malagasy patients].
    Ramanampamonjy RM; Razafimahefa SH; Rajaonarivelo P; Rajaona HR
    Bull Soc Pathol Exot; 2007 Feb; 100(1):28-9. PubMed ID: 17402690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.